Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-12

Clinical Trial Update: Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sequential vaccination with the inactivated poliovirus vaccine (IPV) followed by oral poliovirus vaccine (OPV) versus OPV alone for po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPOL (inactivated poliovirus vaccine)
  • Oral Polio Vaccine (OPV) (oral polio vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Polio, Poliomyelitis | Phase 4 | Status: COMPLETED